CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

45 hedge funds and large institutions have $7.15M invested in Celldex Therapeutics in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 8 closing their positions.

Holders
45
Holders Change
-3
Holders Change %
-6.25%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
10
Reduced
8
Closed
8
Calls
$220K
Puts
$57K
Net Calls
+$163K
Net Calls Change
+$111K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.94M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$496K
3
CS
3
Credit Suisse
Switzerland
$58K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$893K
5
MCP
5
Mirador Capital Partners
California
$27K

Top Sellers

1
Invesco
1
Invesco
Georgia
$0
2
SWP
2
Stratos Wealth Partners
Ohio
$0
3
ARTA
3
A.R.T. Advisors
New York
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$55K
5
BCM
5
Bridgeway Capital Management
Texas
$83K
Name Market Value Shares Shares
Change 		Shares
Change %
JPMorgan Chase & Co
51
JPMorgan Chase & Co
New York
$0 66 – –
CFGS
52
Concourse Financial Group Securities
Alabama
– – – –
HWA
53
HHM Wealth Advisors
Tennessee
$0 20 +20 New
Wells Fargo
54
Wells Fargo
California
$0 330 +25 +8%
Northwestern Mutual Wealth Management
55
Northwestern Mutual Wealth Management
Wisconsin
$0 100 +100 New
II
56
Inspire Investing
Idaho
$0 178 +178 New
1 2
3